Search - tctmd.com

Displaying 101 - 120 of 127

Sort: Relevancy | Date

Presentation ECHO/IMAGING 2019

LV Dysfunction Following Successful MV Repair

Presenter: Gerard P. Aurigemma

March 23, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Opinion Off Script ACC 2019

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

Kwan S. Lee

March 17, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

Presentation CHIP at ACC 2019

High Risk Complex PCI-with LV support

Presenter: Ashish Pershad

March 15, 2019

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

Presentation CRT 2019

LAMPOON to prevent LVOT Obstruction during Transcatheter Mitral Valve Replacement (TMVR): Prospective Multicenter Trial Results

Presenter: Jaffar M. Khan

March 05, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

Todd Neale

January 29, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Todd Neale

January 09, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

Manuscript

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

December 21, 2018

Manuscript

A Paradox between LV Mass Regression and Hemodynamic Improvement after Surgical and Transcatheter Aortic Valve Replacement

May 09, 2017

Advertisement

LV Dysfunction Following Successful MV Repair

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

High Risk Complex PCI-with LV support

CABG vs PCI in Left Main Disease: The Debate Continues

LAMPOON to prevent LVOT Obstruction during Transcatheter Mitral Valve Replacement (TMVR): Prospective Multicenter Trial Results

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

A Paradox between LV Mass Regression and Hemodynamic Improvement after Surgical and Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content